Stay updated on MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Sign up to get notified when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.
Latest updates to the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check14 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check22 days agoChange DetectedThe article on the feasibility and safety of MB-102 in ocular angiography has been updated with a new version dated 2024-11-25, replacing the previous version from 2024-06-25.SummaryDifference0.7%
- Check29 days agoChange DetectedNo new additions were noted, but a significant section of content related to data download options and study details has been removed.SummaryDifference14%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options for data in various formats (CSV, JSON, RIS, FHIR) and allowing users to select specific fields for download.SummaryDifference16%
- Check51 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
Stay in the know with updates to MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.